TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: q-space displacement values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: q-space probability values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: fractional anisotropy values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: increase in hair count
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: satisfactory transfusion rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intraoperative air leak intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative air leakage duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in dermis density
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Reduction of dermis thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Quality-adjusted life year gains
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in 30 Hz flicker response amplitude
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of symptomatic pulmonary embolism (PE)
Endpoint domain: Mortality/survival
Primary endpoint: Erythrocyte sedimentation rate (ESR) improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concordance with ADA standards of care
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean time for clinical improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean time for reduction of cavity size to 50%
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: primary composite end-point of CV death, nonfatal MI or nonfatal stroke
Endpoint domain: Mortality/survival
Primary endpoint: satisfaction with the programme
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: confidence in case management skills
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: preparedness for case manager role activities
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Clinically relevant improvement in goal attainment scaling scores
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Informed patient-centered decisions
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: neurobehavior
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: plantar fascia thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: fat pad thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: VAS
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: Procedural success
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of TLD‐associated adverse airway effects requiring intervention
Endpoint domain: Adverse events/effects
Primary endpoint: Improvements in lung function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Seroprotection rate against diphtheria
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Seroprotection rate against tetanus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Geometric mean titer for antibodies against diphtheria
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Geometric mean titer for antibodies against tetanus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Incidence of intraoperative awareness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Negative urinalyses for opioids
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in injection-related risk behaviors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Weight loss of 5 kg or more
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum creatinine (SCrea)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: time needed to resume normal lifestyle and activity
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: New pulmonary embolism (PE) occurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Pulmonary perfusion improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Discectomy amount of nucleus pulposus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lower back pain VAS score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lower extremities VAS score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in left ventricular ejection fraction (EF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Survival associated with recovery of EF to >40%
Endpoint domain: Mortality/survival
Primary endpoint: Change in subjective pain intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Descriptive norms estimation
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Perception of friends' disapproval
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Risk diversity among patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pharmacokinetics of R(+)‐acenocoumarol
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pharmacokinetics of S(‐)‐acenocoumarol
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pharmacodynamic parameters of acenocoumarol
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: D-dimer decrease at day 4
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reduction of dental anxiety
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: LYG (Life Years Gained)
Endpoint domain: Mortality/survival
Primary endpoint: Incidence of significant posterior pericardial effusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Incidence of late cardiac tamponade
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Incidence of postoperative new-onset atrial fibrillation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Effective rate for gingivitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effective rate for periodontitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CSA knowledge
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: EPO-hemoglobin ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Azygos blood flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Expectation of complete recovery
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Step count accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Distance measurement consistency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement of clinical conditions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Increase of spectral power and normalization of frequency alpha band of parietal-occipital EEG
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: death and dependency
Endpoint domain: Mortality/survival
Primary endpoint: total burden score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: emotional burden score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: time-dependent burden score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: developmental burden score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: End diastolic volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Severity of IVH (grade 4)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Ductal closure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Requirement for bladder catheterization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Adherence to the manual
Endpoint domain: Delivery of care
Primary endpoint: Carbon monoxide diffusing capacity (DL(CO))
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Risk of suicidality
Endpoint domain: Adverse events/effects
Primary endpoint: Embolic events
Endpoint domain: Mortality/survival
Primary endpoint: GIQLI scores normalization
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Patient satisfaction with operation
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: mean entrance skin dose reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: interpersonal relationship
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: school adjustment
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Mean serum total cortisol levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Re-exacerbation risk
Endpoint domain: Adverse events/effects
Primary endpoint: Serum parathyroid hormone (S-PTH)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Serum phosphate (S-Pi)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Urinary phosphate (U-Pi)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Increase in VO(2)max
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Correlation of PD and AUC of the TB curve with mean density of MB
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Hemolysis levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of relapse and death within 30 days
Endpoint domain: Mortality/survival
Primary endpoint: gait-analysis parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: passive ankle motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ankle dorsiflexor strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lipid profile (total cholesterol and triglycerides)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: overall-accumulated morphine consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sustained arrhythmias
Endpoint domain: Adverse events/effects
Primary endpoint: Vital signs change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of women meeting the IOM guidelines
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: End-of-pregnancy weight goal achievement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postpartum weight retention reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HPV infection incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: CIN1+ lesions incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: CIN2+ lesions incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Forced expiratory volume in 1 sec (Fev1)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Physical Component Score of SF-36
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: positive symptom improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effectiveness of thiazides as diuretics and antihypertensive agents
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: composite score for primary criteria (itching, tearing, and conjunctival hyperemia)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post‐vaccination rSBA geometric mean titers (GMTs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Emboli rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean number of cigarettes smoked per day
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk for mastitis
Endpoint domain: Adverse events/effects
Primary endpoint: Any breastfeeding problems during the first month
Endpoint domain: Adverse events/effects
Primary endpoint: Cessation of breastfeeding earlier than at 4 months
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Upper-body strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of mid- and late-life events reported
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: memories detail level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: self-concept ratings
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Thickness of hybrid layer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Extent of adhesive encapsulation of demineralised dentine matrix
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Aggressiveness of self-etching systems
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: efficacy of ceftriaxone vs amoxicillin clavulanate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: overall cognitive functions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: risk of Mild Cognitive Impairment (MCI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Pain score on the visual analog scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recovery time to daily life
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Safety profile of etanercept
Endpoint domain: Adverse events/effects
Primary endpoint: Minor wound infections
Endpoint domain: Adverse events/effects
Primary endpoint: Major wound infections
Endpoint domain: Adverse events/effects
Primary endpoint: Testing positive for substances
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Plasma PYY concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Hunger
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Motivation to eat
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Late postoperative complications
Endpoint domain: Adverse events/effects
Primary endpoint: Reoperation for complications
Endpoint domain: Adverse events/effects
Primary endpoint: Child bedtime behavioral difficulties
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of excellent images
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: motion artifacts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improved performance status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PEPI score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ki67 suppression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sCr level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Total morphine use (mg/kg/24 h)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of morphine boluses administered
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ramsay score of 1 (inadequate sedation)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: likelihood of any hospitalization
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Measures of concentration, sustained attention, and psychomotor speed
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Debilitating fatigue
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Improvement in Jebsen-Taylor Hand Function Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Grasp strength of the trained hand
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acceptable performance on real patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in ESAS scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum C-reactive protein (CRP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Eccentric Hamstring (EH) torque and Concentric Quadriceps (CQ) power
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of cephalic version
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Proportion of Cesarean sections indicated for breech presentation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Frequency of PID
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Gestational weight gain (EGWG)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Glycemic index (GI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: 6-month mortality risk
Endpoint domain: Mortality/survival
Primary endpoint: short-term MACE
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: long-term MACE
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Right ventricular end-systolic volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Oxygenation index (PaO(2)/FiO(2))
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Preference for compression technique
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: alpha 1-microglobulin level in urine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: urine production
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Rate of severe bronchopulmonary dysplasia (BPD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Progression in LM
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in AL
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: oseltamivir area under the plasma concentration‐time curve (AUC) from 0 to 6 h
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: metabolite/oseltamivir AUC0 → 6 h ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Knowledge acquisition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in Y-BOCS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean diameter of coronary arteries
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: substantial improvement in physical functioning
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Cleveland Clinic continence score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: American Medical System score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anal manometry resting pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Medical clearance obtained
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Bloodspot area
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in ETP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Delay in thrombin generation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: 10-year patient survival
Endpoint domain: Mortality/survival
Primary endpoint: median serum creatinine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: requirement for antihypertensive treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: breastfeeding duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes